| Paula Rodriguez-pranaitis, | |
|
47 Town St, Norwich, CT 06360-2323 | |
| (413) 846-0445 | |
| Not Available |
| Full Name | Paula Rodriguez-pranaitis |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 47 Town St, Norwich, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013378728 | NPI | - | NPPES |
| M18463 | Other | MA | BLUE CROSS BLUE SHIELD |
| 1303295 | Medicaid | MA | |
| 1307576 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Entity Name | United Community And Family Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467482539 PECOS PAC ID: 9032012497 Enrollment ID: O20040202000086 |
News Archive
Potatoes are often equated with refined grains due to their carbohydrate content. Yet, potatoes contain fiber, resistant starch, and key micronutrients that Americans need more of in their diet.
ResMed Inc. announced today that its two-for-one stock split of the company's outstanding shares of common stock, payable in the form of a 100% stock dividend was completed on August 30, 2010.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
Researchers at the University of Cincinnati have received a five-year grant to develop rapid, robust, user-friendly diagnostics for influenza virus. An interdisciplinary team of scientists has received a $2.3 million dollar grant from the National Institute for Allergy and Infectious Diseases, one of the National Institutes of Health. The name of the grant is "Glycan Receptor Mimics for Rapid Detection, Typing, and Susceptibility Testing of Influenza."
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paula Rodriguez-pranaitis, 47 Town St, Norwich, CT 06360-2323 Ph: (860) 822-4177 | Paula Rodriguez-pranaitis, 47 Town St, Norwich, CT 06360-2323 Ph: (413) 846-0445 |
News Archive
Potatoes are often equated with refined grains due to their carbohydrate content. Yet, potatoes contain fiber, resistant starch, and key micronutrients that Americans need more of in their diet.
ResMed Inc. announced today that its two-for-one stock split of the company's outstanding shares of common stock, payable in the form of a 100% stock dividend was completed on August 30, 2010.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
Researchers at the University of Cincinnati have received a five-year grant to develop rapid, robust, user-friendly diagnostics for influenza virus. An interdisciplinary team of scientists has received a $2.3 million dollar grant from the National Institute for Allergy and Infectious Diseases, one of the National Institutes of Health. The name of the grant is "Glycan Receptor Mimics for Rapid Detection, Typing, and Susceptibility Testing of Influenza."
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 5 days ago
Megan Renee Eddy, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 119 Lafayette St, Norwich, CT 06360 Phone: 860-889-0097 Fax: 860-889-3184 | |
Charlotte T Farmer, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 18 Oneco St Ste 3, Norwich, CT 06360 Phone: 860-861-5448 | |
Jill E Roediger, L.A.D.C., C.A.D.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 110 Main St, Norwich, CT 06360 Phone: 860-892-9002 Fax: 860-892-9009 | |
Randolph Brooks, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Connecticut Ave, Norwich, CT 06360 Phone: 860-889-7274 | |
Maridalia M Hernandez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 55 Main St, Norwich, CT 06360 Phone: 860-885-6054 | |
Nicole Marie Krys, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 69 Roosevelt Ave, Norwich, CT 06360 Phone: 860-912-1147 |